Table 6 Vasoconstrictor drugs contraindicated or used with precautions for Raynaud’s phenomenon
From: French recommendations for the management of systemic sclerosis
Nasal decongestants by local or general administration |
|---|
 Pseudoephedrine |
 Phenylephrine |
 Phenylpropanolamine |
Migraine drugs derived from ergot |
 Dihydroergotamine |
 Ergotamine |
Beta-blockers |
Anti-glaucoma beta-blocker eye drops |
Hyperprolactinemia treatments |
 Bromocriptine |
 Cabergoline |
 Lisuride |
Antiparkinsonians |
 Pergolide |